2019 in Review
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
58 Results
Clear Filters
NYSCF, Johns Hopkins, and Bloomberg Philanthropies Partner to Advance Precision Medicine
A new collaboration between the NYSCF Research Institute, Johns Hopkins University School of Medicine (JHUSOM), and Bloomberg Philanthropies is aiming to push precision medicine forward using...
Bloomberg Philanthropies, Johns Hopkins University School of Medicine, and The New York Stem Cell Foundation Research Institute Announce an Unprecedented Effort to Advance Precision Medicine
Unmatched Scope of Resources Will Identify Distinctive Disease Mechanisms in Small Patient Subgroups, Supporting Development of Custom Therapeutic Approaches New York, NY (October 22, 2019) –...
Alzheimer’s Stem Cells are Uncovering Disease Mechanisms, and NYSCF is Making Them Widely Available to the Research Community
One of the great advantages of stem cells is that they can be used to make personalized models of disease — they let us study exactly...
To Make New Neurons, Alzheimer’s-Affected Brains Need to do Some Cleaning
The Context: Alzheimer’s-affected brains do not make new neurons out of neural stem cells as efficiently as healthy brains, and this is an early sign of...
CRISPR to the RESCUE: Gene Editing Technology Gets More Versatile
The Context: CRISPR is a powerful gene editing tool which traditionally works by locating and modifying stretches of DNA within the genome. However, this technique creates...
Stem Cells, Alzheimer’s, and Caregiving: Susan L. Solomon Guests Stars on the “Thank You Dan and Alex” Podcast
“Stem cells allow us to understand what exactly is broken, and therefore, what needs to be fixed,” NYSCF CEO Susan L. Solomon explained. “The problem with...
NYSCF Hosts Panel Discussion on the Future of Alzheimer’s Research and Treatment
44 million people worldwide are affected by Alzheimer’s. 1 in 3 seniors will die with it or a related dementia. The cost of treating Alzheimer’s is...
New York Stem Cell Foundation Research Institute and Tufts University to Collaborate on Neurodegeneration
Scientific teams will develop advanced stem cell models to improve understanding and treatment of Parkinson’s, Alzheimer’s, and similar diseases New York, NY (September 12, 2018) –...
2017 Year in Review
As we enter 2018, NYSCF is taking a moment to look back on the milestones of 2017. With your support, we accelerated our research, began new...
NYSCF and Mount Sinai Researchers Recapitulate Alzheimer’s Disease in the Laboratory
NYSCF Research Institute scientists in collaboration with researchers at the Icahn School of Medicine at Mount Sinai refined a technique to turn skin cells from patients...
NYSCF Innovators Derive Microglia From Stem Cells
Your body is full of immune cells that fight off infection and illness. You’ve probably heard of a few of them: white blood cells, B cells,...
Visual Stimulation Treats Alzheimer’s Plaques in Mice
NYSCF – Robertson Neuroscience Investigator Dr. Ed Boyden and his team at MIT Media Lab published their latest work on an exciting new, noninvasive approach to treating...
NYSCF Research Institute and Yumanity Therapeutics Announce Discovery Collaboration
The NYSCF Research Institute announced a new collaboration with Yumanity Therapeutics, a company focused on transforming drug discovery for diseases caused by protein misfiling, to generate...
New Type of Stem Cells that Accelerate Discovery
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
NYSCF Quoted in The Wall Street Journal on Experimental Alzheimer’s Drug Testing
Bringing treatments out of laboratories and into clinics remains a major obstacle for healthcare. Mice and other common lab animals cannot reliably predict human responses to...
Visiting NYSCF Researcher Studies The Role of Vitamin B1 in Alzheimer’s Disease
Dr. Gary Gibson, Director of the Laboratory for Mitochondrial Biology and Metabolic Dysfunction in Neurodegeneration at Weill Cornell Medical College, joined NYSCF as a visiting scientist...
NYSCF Featured Speaker at Alzheimer’s Disease Conference
Dr. Scott Noggle, NYSCF Vice President for Stem Cell Research, presented NYSCF’s latest Alzheimer’s disease research as the keynote speaker at the Alzheimer’s Disease Resource Center’s...
NYSCF Travels Out East to Discuss Latest Research
In conjunction with the Alzheimer’s Disease Resource Center (ADRC), NYSCF presented their latest Alzheimer’s research at the Jewish Center of the Hamptons in East Hampton. Presentations...
NYSCF Speaks at Leading Alzheimer’s Conference
Dr. Scott Noggle, Director of the NYSCF Laboratory and NYSCF – Charles Evans Senior Research Fellow for Alzheimer’s Disease, presented the latest in Alzheimer’s research at the...
NYSCF Researchers Identify New Gene Targets in Early-Onset Alzheimer’s
NYSCF scientists, in collaboration with scientists from the Icahn School of Medicine at Mount Sinai, successfully created and used a stem cell model of familial Alzheimer’s...
NYSCF Scientists Make Living Brain Cells From Deceased Alzheimer’s Patients Biobanked Brain Tissue
NYSCF scientists, in collaboration with scientists from Columbia University Medical Center, successfully generated induced pluripotent stem cells and, subsequently, neurons from non-cryoprotected biobanked brain tissue of...
NYSCF Collaborates on Large Scale Alzheimer’s Research Program with Mount Sinai
Announced today, NYSCF will be the lead stem cell partner in an Alzheimer's consortia with scientists at Icahn School of Medicine at Mount Sinai and other...
Colombian Alzheimer’s Disease Study Reveals Changes to Brain Before Symptoms
A large, extended Colombian family gripped by early-onset Alzheimer’s disease has helped researchers led by Eric Reiman, MD, determine how early (and rapidly) changes to the...
NYSCF Scientists Develop iPS Cell Model of Alzheimer’s Disease, A Key Step to Understanding Disease
At the Alzheimer’s Association International Conference this past July, Andrew Sproul, PhD, a NYSCF Postdoctoral Associate, presented NYSCF’s latest efforts to understand Alzheimer’s disease. They have...